Literature DB >> 18248403

Use of econometric models to estimate expenditure shares.

Justin G Trogdon1, Eric A Finkelstein, Thomas J Hoerger.   

Abstract

OBJECTIVE: To investigate the use of regression models to calculate disease-specific shares of medical expenditures. DATA SOURCES/STUDY
SETTING: Medical Expenditure Panel Survey (MEPS), 2000-2003. STUDY
DESIGN: Theoretical investigation and secondary data analysis. DATA COLLECTION/EXTRACTION
METHODS: Condition files used to define the presence of 10 medical conditions. PRINCIPAL
FINDINGS: Incremental effects of conditions on expenditures, expressed as a fraction of total expenditures, cannot generally be interpreted as shares. When the presence of one condition increases treatment costs for another condition, summing condition-specific shares leads to double-counting of expenditures.
CONCLUSIONS: Condition-specific shares generated from multiplicative models should not be summed. We provide an algorithm that allows estimates based on these models to be interpreted as shares and summed across conditions.

Mesh:

Year:  2008        PMID: 18248403      PMCID: PMC2517274          DOI: 10.1111/j.1475-6773.2007.00827.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  12 in total

1.  Much ado about two: reconsidering retransformation and the two-part model in health econometrics.

Authors:  J Mullahy
Journal:  J Health Econ       Date:  1998-06       Impact factor: 3.883

2.  State-level estimates of annual medical expenditures attributable to obesity.

Authors:  Eric A Finkelstein; Ian C Fiebelkorn; Guijing Wang
Journal:  Obes Res       Date:  2004-01

Review 3.  Why population attributable fractions can sum to more than one.

Authors:  Alexander K Rowe; Kenneth E Powell; W Dana Flanders
Journal:  Am J Prev Med       Date:  2004-04       Impact factor: 5.043

Review 4.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

5.  A comparison of the case-control and case-crossover designs for estimating medical costs of nonfatal fall-related injuries among older Americans.

Authors:  Eric A Finkelstein; Hong Chen; Ted R Miller; Phaedra S Corso; Judy A Stevens
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

6.  Generalized modeling approaches to risk adjustment of skewed outcomes data.

Authors:  Willard G Manning; Anirban Basu; John Mullahy
Journal:  J Health Econ       Date:  2005-05       Impact factor: 3.883

7.  A robust approach for skewed and heavy-tailed outcomes in the analysis of health care expenditures.

Authors:  Eva Cantoni; Elvezio Ronchetti
Journal:  J Health Econ       Date:  2006-01-04       Impact factor: 3.883

Review 8.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

9.  Sequential and average attributable fractions as aids in the selection of preventive strategies.

Authors:  G E Eide; O Gefeller
Journal:  J Clin Epidemiol       Date:  1995-05       Impact factor: 6.437

10.  Excess deaths associated with underweight, overweight, and obesity.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

View more
  18 in total

1.  Explaining The Slowdown In Medical Spending Growth Among The Elderly, 1999-2012.

Authors:  David M Cutler; Kaushik Ghosh; Kassandra L Messer; Trivellore E Raghunathan; Susan T Stewart; Allison B Rosen
Journal:  Health Aff (Millwood)       Date:  2019-02       Impact factor: 6.301

2.  Guidelines for Measuring Disease Episodes: An Analysis of the Effects on the Components of Expenditure Growth.

Authors:  Abe Dunn; Eli Liebman; Lindsey Rittmueller; Adam Hale Shapiro
Journal:  Health Serv Res       Date:  2016-05-03       Impact factor: 3.402

3.  A new methodological approach to adjust alcohol exposure distributions to improve the estimation of alcohol-attributable fractions.

Authors:  William J Parish; Arnie Aldridge; Benjamin Allaire; Donatus U Ekwueme; Diana Poehler; Gery P Guy; Cheryll C Thomas; Justin G Trogdon
Journal:  Addiction       Date:  2017-06-23       Impact factor: 6.526

4.  A Satellite Account for Health in the United States.

Authors:  David M Cutler; Kaushik Ghosh; Kassandra L Messer; Trivellore Raghunathan; Allison B Rosen; Susan T Stewart
Journal:  Am Econ Rev       Date:  2022-02

5.  Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.

Authors:  Paul A Heidenreich; Nancy M Albert; Larry A Allen; David A Bluemke; Javed Butler; Gregg C Fonarow; John S Ikonomidis; Olga Khavjou; Marvin A Konstam; Thomas M Maddox; Graham Nichol; Michael Pham; Ileana L Piña; Justin G Trogdon
Journal:  Circ Heart Fail       Date:  2013-04-24       Impact factor: 8.790

Review 6.  Challenges in building disease-based national health accounts.

Authors:  Allison B Rosen; David M Cutler
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

7.  State-level estimates of cancer-related absenteeism costs.

Authors:  Florence K Tangka; Justin G Trogdon; Isaac Nwaise; Donatus U Ekwueme; Gery P Guy; Diane Orenstein
Journal:  J Occup Environ Med       Date:  2013-09       Impact factor: 2.162

8.  State-level cancer treatment costs: how much and who pays?

Authors:  Florence K Tangka; Justin G Trogdon; Donatus U Ekwueme; Gery P Guy; Isaac Nwaise; Diane Orenstein
Journal:  Cancer       Date:  2013-04-04       Impact factor: 6.860

9.  The economic burden of vision loss and eye disorders among the United States population younger than 40 years.

Authors:  John S Wittenborn; Xinzhi Zhang; Charles W Feagan; Wesley L Crouse; Sundar Shrestha; Alex R Kemper; Thomas J Hoerger; Jinan B Saaddine
Journal:  Ophthalmology       Date:  2013-04-28       Impact factor: 12.079

10.  State-level projections of cancer-related medical care costs: 2010 to 2020.

Authors:  Justin G Trogdon; Florence K L Tangka; Donatus U Ekwueme; Gery P Guy; Isaac Nwaise; Diane Orenstein
Journal:  Am J Manag Care       Date:  2012-09       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.